ArticleMolecular pharmaceutics2026

Syntheses, Biological and Preclinical Evaluations, and Nanoparticle Formulations of the ROS-Activatable Prodrugs of Doxazolidine for Drug-Resistant Cancer Therapy.

Ryo Tamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.